This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study.
Cancer immunology, immunotherapy : CII, 64(2), 237-47
Citation
Wesa, Kathleen M; Cunningham-Rundles, Susanna; Klimek, Virginia M; Vertosick, Emily; Coleton, Marci I; Yeung, K Simon; Lin, Hong; Nimer, Stephen; Cassileth, Barrie R. (2015). Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study.. Cancer immunology, immunotherapy : CII, 64(2), 237-47. https://doi.org/10.1007/s00262-014-1628-6